Lanreotide market Worldwide Industry Analysis, Future Demand and Forecast till 2029

Lanreotide injection is used to treat patients who have acromegaly and who have not responded to surgery or radiation. Lanreotide injection is also used to treat patients who have neuroendocrine tumours of the GI tract or pancreas (GEP-NETs) that have spread or cannot be removed surgically. Lanreotide injection belongs to the somatostatin agonist family of drugs. It works by lowering the number of specific hormones that the body produces.

According to the American Association of Neurological Surgeons, Cushing's disease affects around 10-15 million people each year. Furthermore, the condition primarily affects people aged 20 to 50 years old, with females having a higher prevalence than males. Furthermore, according to NCBI in 2018, the global prevalence of acromegaly is around 4,600 per million people. Acromegaly is also seen in about 116.9 new cases per million per year across the world. Thus the rising incidences of such rare diseases act as a driver for the global Lanreotide market.

Another important driver to the overall market growth is the availability of attractive government insurance plans and programmes for people with rare illnesses. For instance, several government healthcare institutions in the US and Europe, like the National Institutes of Health (NIH) and the National Center for Advancing Translational Sciences (NCATS), provide subsidised medications for rare disorders.

Furthermore, in June 2019, the US Food and Drug Administration (FDA) authorised a new pre-filled syringe for Somatuline Depot (lanreotide)  of Ipsen Biopharmaceuticals, a subsidiary of Ipsen. The syringe has been modified with new features such as bigger flanges to make injection administration easier for healthcare practitioners.

To Request a Sample of our Report on Lanreotide Market:   https://www.omrglobal.com/request-sample/lanreotide-market

Market Coverage

The market number available for - 2021-2029
Base year- 2021
Forecast period- 2023-2029

Segment Covered- 

By Type
By Outlook
By Application

Regions Covered

North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape: Ipsen Pharmaceuticals, Bachem AG, AmbioPharm, ChemWerth Inc., Techland Corporation, 

Lanreotide Market by Segments

By Type

60mg
90mg
120mg

By Outlook

Neuroendocrine Tumors
Acromegaly

By Application

Hospital
Pharmacy

A full Report of Lanreotide Market is Available: https://www.omrglobal.com/industry-reports/lanreotide-market

 Lanreotide Market by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/lanreotide-market

https://monblogapple.com/2023/05/13/le-marche-des-proteines-de-bouillon-dos-devrait-augmenter-a-un-tcac-stable-au-cours-de-la-periode-de-prevision-2023-a-2029/
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/%ec%83%81%ec%97%85%ec%9a%a9-%ed%95%b4%ec%a1%b0%eb%a5%98-%ec%8b%9c%ec%9e%a5-%ea%b0%80%ec%b9%98%eb%8a%94-2029%eb%85%84%ea%b9%8c%ec%a7%80-%ed%99%95%ec%9e%a5%eb%90%a0-%ea%b2%83%ec%9c%bc%eb%a1%9c-%ec%98%88/122840/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d9%8a%d8%b1%d8%aa%d9%81%d8%b9-%d8%b3%d9%88%d9%82-%d8%a3%d8%ac%d9%87%d8%b2%d8%a9-%d8%a7%d9%84%d8%a7%d8%b3%d8%aa%d8%b4%d8%b9-22/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

 About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.